APA

Dawson M. I., Jong L., Hobbs P. D., Xiao D., Feng K. C., Chao W. R., Pan C., Fontana J. A. & Zhang X. K. (20001115). 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists. : Bioorganic & medicinal chemistry letters.

Chicago

Dawson M I, Jong L, Hobbs P D, Xiao D, Feng K C, Chao W R, Pan C, Fontana J A and Zhang X K. 20001115. 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists. : Bioorganic & medicinal chemistry letters.

Harvard

Dawson M. I., Jong L., Hobbs P. D., Xiao D., Feng K. C., Chao W. R., Pan C., Fontana J. A. and Zhang X. K. (20001115). 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists. : Bioorganic & medicinal chemistry letters.

MLA

Dawson M I, Jong L, Hobbs P D, Xiao D, Feng K C, Chao W R, Pan C, Fontana J A and Zhang X K. 4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists. : Bioorganic & medicinal chemistry letters. 20001115.